ARS Pharmaceuticals Inc

NASDAQ:SPRY 4:00:00 PM EDT

7.47

-0.18 (-2.35%)

7:59:51 PM EDT: $7.65 +0.18 (+2.41%)

Market Cap (Intraday)	700.48M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.08 Million
Adjusted EPS	-$0.22

See more estimates

10-Day MA	$7.16
50-Day MA	$7.34
200-Day MA	$5.40

See more pivots

ARS Pharmaceuticals Inc Stock, NASDAQ:SPRY

11682 El Camino Real, Suite 120, San Diego, California 92130

United States of America

Phone: +1.858.771.9307

Number of Employees: 90

Description

ARS Pharmaceuticals, Inc. engages in developing neffyâ„¢, an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications, and insect bites that could lead to life-threatening anaphylaxis. The company is headquartered in San Diego, CA.